Population pharmacokinetics of imatinib in patients with pulmonary arterial hypertension

被引：0
|
作者：
Bouillon, Thomas [1 ]
Renard, Didier [1 ]
Zhou, Ping [2 ]
Flesch, Gerard [1 ]
Quinn, Debbie [3 ]
机构：
[1] Novartis Pharma AG, Modeling & Simulat, CH-4002 Basel, Switzerland
[2] Novartis Horsham Res Ctr, Drug Metab & Pharmacokinet, Horsham, W Sussex, England
[3] Novartis Pharmaceut, Crit Care, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Pulmonary hypertension;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
556
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evaluation of treatment strategy transitions in a population of patients with pulmonary arterial hypertension
    D'Araujo, Sandy Carolino
    Vachiey, Jean-Luc
    ACTA CARDIOLOGICA, 2023, 78 : 36 - 36
  • [42] Comparison of Effects of Imatinib and Nilotinib in a Rodent Model of Pulmonary Arterial Hypertension
    Duggan, N.
    Bonneau, O.
    Hussey, M.
    Quinn, D. A.
    Manley, P.
    Walker, C.
    Westwick, J.
    Thomas, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [43] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Frost, Adaani E.
    Barst, Robyn J.
    Hoeper, Marius M.
    Chang, Hyuk-Jae
    Frantz, Robert P.
    Fukumoto, Yoshihiro
    Galie, Nazzareno
    Hassoun, Paul M.
    Klose, Hans
    Matsubara, Hiromi
    Morrell, Nicholas W.
    Peacock, Andrew J.
    Pfeifer, Michael
    Simonneau, Gerald
    Tapson, Victor F.
    Torres, Fernando
    Vizza, Carmine Dario
    Lawrence, David
    Yang, Wei
    Felser, James M.
    Quinn, Deborah A.
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (11): : 1366 - 1375
  • [44] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Hoeper, Marius
    Barst, Robyn
    Galie, Nazzareno
    Hassoun, Paul
    Morrell, Nicholas
    Peacock, Andrew
    Simonneau, Gerald
    Tapson, Victor
    Torres, Fernando
    Lawrence, David
    Quinn, Deborah
    Ghofrani, Hossein Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [45] Pharmacokinetics of ambrisentan in a patient with Pulmonary Arterial Hypertension and a total gastrectomy
    Abston, Eric
    Farber, Harrison W.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2019, 57
  • [46] Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending-dose study
    Small, David
    Ferguson-Sells, Lisa
    Dahdah, Nagib
    Bonnet, Damien
    Landry, John
    Li, Baohui
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (10) : 2302 - 2309
  • [47] Tachyarrhythmias in patients with pulmonary arterial hypertension
    P-Y, S.
    Jing, Z. -C.
    Zhao, Q. -H.
    Jiang, X.
    Yang, Z. -J.
    He, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 756 - 757
  • [48] Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension
    Ait-Oudhia, Sihem
    Jaworowicz, David
    Hu, Ziheng
    Bihorel, Sebastien
    Hu, Shuai
    Balasubrahmanyam, Budda
    Mistry, Bipin
    Pena, Janethe de Oliveira
    Wenning, Larissa
    Gheyas, Ferdous
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (08): : 1380 - 1393
  • [49] EFFICACY OF MACITENTAN IN A LARGE, REAL LIFE POPULATION OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Nashat, H.
    Barbosa, J.
    Harries, C.
    Price, L.
    McCabe, C.
    Kempny, A.
    Wort, S. J.
    Gatzoulis, M. A.
    Dimopoulos, K.
    THORAX, 2018, 73 : A76 - A76
  • [50] Exercise in patients with pulmonary arterial with hypertension
    Desai, Smita A.
    Channick, Richard N.
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2008, 28 (01) : 12 - 16
12345